Suzy Cros

687 total citations
17 papers, 585 citations indexed

About

Suzy Cros is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Suzy Cros has authored 17 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Organic Chemistry. Recurrent topics in Suzy Cros's work include Cancer therapeutics and mechanisms (7 papers), Metal complexes synthesis and properties (5 papers) and Cancer Treatment and Pharmacology (3 papers). Suzy Cros is often cited by papers focused on Cancer therapeutics and mechanisms (7 papers), Metal complexes synthesis and properties (5 papers) and Cancer Treatment and Pharmacology (3 papers). Suzy Cros collaborates with scholars based in France, Canada and United States. Suzy Cros's co-authors include Tam Ha, Jean Pierre Souchard, Neil P. Johnson, Franz L. Wimmer, Nicholas P. Farrell, André L. Beauchamp, Claude Paoletti, Paule Castan, Smita Wimmer and Jean‐François Labarre and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and Cancer Letters.

In The Last Decade

Suzy Cros

17 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzy Cros France 13 336 277 235 78 77 17 585
Gilda Saluta United States 14 378 1.1× 346 1.2× 317 1.3× 80 1.0× 62 0.8× 18 746
Omoshile Clement United States 13 127 0.4× 251 0.9× 260 1.1× 89 1.1× 107 1.4× 22 672
Kouichi Uoto Japan 18 292 0.9× 517 1.9× 389 1.7× 56 0.7× 83 1.1× 45 939
Keith Vaughan Canada 16 86 0.3× 668 2.4× 216 0.9× 65 0.8× 66 0.9× 103 948
Johnny Easmon Austria 12 358 1.1× 537 1.9× 363 1.5× 90 1.2× 174 2.3× 22 1.1k
S.R. Brunette United States 5 211 0.6× 250 0.9× 409 1.7× 52 0.7× 49 0.6× 7 606
Miguel F. Braña Spain 17 188 0.6× 728 2.6× 539 2.3× 65 0.8× 51 0.7× 57 1.1k
Gerald W. Shipps United States 20 119 0.4× 265 1.0× 510 2.2× 76 1.0× 49 0.6× 33 804
Carsten A. Vock Germany 12 357 1.1× 448 1.6× 137 0.6× 70 0.9× 108 1.4× 19 704
Giorgio Gaudiano Italy 15 185 0.6× 416 1.5× 328 1.4× 35 0.4× 40 0.5× 46 763

Countries citing papers authored by Suzy Cros

Since Specialization
Citations

This map shows the geographic impact of Suzy Cros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzy Cros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzy Cros more than expected).

Fields of papers citing papers by Suzy Cros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzy Cros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzy Cros. The network helps show where Suzy Cros may publish in the future.

Co-authorship network of co-authors of Suzy Cros

This figure shows the co-authorship network connecting the top 25 collaborators of Suzy Cros. A scholar is included among the top collaborators of Suzy Cros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzy Cros. Suzy Cros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Monsarrat, Bernard, Étienne Chatelut, Isabelle Royer, et al.. (1998). Modification of paclitaxel metabolism in a cancer patient by induction of cytochrome P450 3A4.. PubMed. 26(3). 229–33. 67 indexed citations
2.
Camus, Anne, Jacqueline Barra, Patrick Dumont, et al.. (1996). Transgenic mice expressing the Sh ble bleomycin resistance gene are protected against bleomycin-induced pulmonary fibrosis.. PubMed. 56(24). 5659–65. 4 indexed citations
3.
Roux‐Dalvai, Florence, Nicoletta Galeotti, Joël Poncet, et al.. (1994). Synthesis and in vitro cytotoxicity of diastereoisomerically modified dolastatin 15 analogues. Bioorganic & Medicinal Chemistry Letters. 4(16). 1947–1950. 6 indexed citations
4.
Cros, Suzy, et al.. (1992). In vivo evidence of complete circumvention of vincristine resistance by a new triazinoaminopiperidine derivative S 9788 in P388/VCR leukemia model. Cancer Chemotherapy and Pharmacology. 30(6). 491–494. 16 indexed citations
5.
Etemad‐Moghadam, Guita, et al.. (1991). Syntheses and in vitro evaluation of water-soluble "cationic metalloporphyrin-ellipticine" molecules having a high affinity for DNA. Journal of Medicinal Chemistry. 34(3). 900–906. 30 indexed citations
6.
Jouin, Patrick, et al.. (1991). Antineoplastic activity of didemnin congeners: nordidemnin and modified chain analogs. Journal of Medicinal Chemistry. 34(2). 486–491. 30 indexed citations
7.
Castan, Paule, et al.. (1990). Platinum and palladium complexes of 3-methyl orotic acid: A route toward palladium complexes with good antitumor activity. Journal of Inorganic Biochemistry. 38(3). 225–239. 76 indexed citations
8.
Farrell, Nicholas P., Tam Ha, Jean Pierre Souchard, et al.. (1989). Cytostatic trans-platinum(II) complexes. Journal of Medicinal Chemistry. 32(10). 2240–2241. 151 indexed citations
9.
Li, Ding, Guita Etemad‐Moghadam, Suzy Cros, Christian Auclair, & Bernard Meunier. (1989). Cytotoxic hybrid molecules ‘metalloporphyrin–ellipticine’ having a high affinity for DNA. Journal of the Chemical Society Chemical Communications. 1711–1713. 9 indexed citations
10.
Pratviel, Geneviève, Jean Bernadou, Gérard Meunier, et al.. (1986). Ribose as the preferential target for the oxidized form of elliptinium acetate in ribonucleos(T)ides. Biological activities of the resulting adducts. Journal of Medicinal Chemistry. 29(8). 1350–1355. 14 indexed citations
11.
Macquet, Jean-Pierre, Suzy Cros, & André L. Beauchamp. (1985). Preparation and crystal structure of the hydroxo-bridged complex biscyclo-tri-μ-hydroxo-tris[(trans-1,2-diaminocyclohexane)platinum(II)] tris. Journal of Inorganic Biochemistry. 25(3). 197–206. 18 indexed citations
12.
DeMarini, David M., Suzy Cros, Claude Paoletti, P. Lecointe, & Abraham W. Hsie. (1983). Mutagenicity and cytotoxicity of five antitumor ellipticines in mammalian cells and their structure-activity relationships in Salmonella.. PubMed. 43(8). 3544–52. 35 indexed citations
13.
14.
Labarre, Jean‐François, et al.. (1980). New designs in cyclophosphazenes as antitumour agents. Journal de Chimie Physique. 77. 85–89. 9 indexed citations
15.
Paoletti, Claude, et al.. (1979). Ellipticine and derivatives induce breakage of L1210 cells DNA in vitro. Biochemical Pharmacology. 28(3). 345–350. 32 indexed citations
16.
Labarre, Jean‐François, et al.. (1979). Antitumour activity of some cyclophosphazenes. European Journal of Cancer (1965). 15(5). 637–643. 44 indexed citations
17.
Lecointe, P., P. Lesca, Suzy Cros, & Claude Paoletti. (1978). Some antitumor derivatives of ellipticine deprived of mutagenic properties. Chemico-Biological Interactions. 20(1). 113–121. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026